Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Ilaris
Active Ingredient: Canakinumab 150mg
Dosage Form: Powder for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma Stein AG, Stein, Switzerland
Hameln Pharmaceuticals GmbH, Hameln, Germany
   
Product: Maviret
Active Ingredients: Glecaprevir 100mg
Pibrentasvir 40mg
Dosage Form: Film coated tablet
New Zealand Sponsor: AbbVie Limited
Manufacturers: AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
Fournier Laboratories Ireland Limited, Carrigtwohill, Ireland
   
Product: Ropin
Active Ingredient: Ropinirole hydrochloride 0.285mg equivalent to ropinirole 0.25mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Torrent Pharmaceuticals Limited, Kadi, India
   
Product: Ropin
Active Ingredient: Ropinirole hydrochloride 0.57mg equivalent to ropinirole 0.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Torrent Pharmaceuticals Limited, Kadi, India
   
Product: Ropin
Active Ingredient: Ropinirole hydrochloride 1.14mg equivalent to ropinirole 1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Torrent Pharmaceuticals Limited, Kadi, India
   
Product: Ropin
Active Ingredient: Ropinirole hydrochloride 2.28mg equivalent to ropinirole 2mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Torrent Pharmaceuticals Limited, Kadi, India
   
Product: Ropin
Active Ingredient: Ropinirole hydrochloride 5.7mg equivalent to ropinirole 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Torrent Pharmaceuticals Limited, Kadi, India


Dated this 9th day of April 2020.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).